Cargando…

Smad3 Sensitizes Hepatocelluar Carcinoma Cells to Cisplatin by Repressing Phosphorylation of AKT

Background: Heptocelluar carcinoma (HCC) is insensitive to chemotherapy due to limited bioavailability and acquired drug resistance. Smad3 plays dual roles by inhibiting cell growth initially and promoting the progression of advanced tumors in HCC. However, the role of smad3 in chemosensitivity of H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Hong-Hao, Chen, Lin, Liang, Hui-Fang, Li, Guang-Zhen, Zhang, Bi-Xiang, Chen, Xiao-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849060/ https://www.ncbi.nlm.nih.gov/pubmed/27110775 http://dx.doi.org/10.3390/ijms17040610

Ejemplares similares

Roles of Tumor Microenvironment in Hepatocelluar Carcinoma
por: Seo, Haeng R.
Publicado: (2015)

MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner
por: Huang, Zhao, et al.
Publicado: (2020)

MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma
por: Huang, Jia-Yuan, et al.
Publicado: (2015)

Triptolide sensitizes cisplatin-resistant human epithelial ovarian cancer by inhibiting the phosphorylation of AKT
por: Huang, Genhua, et al.
Publicado: (2019)

Prognostic nomograms for patients with resectable hepatocelluar carcinoma incorporating systemic inflammation and tumor characteristics
por: Shen, Junyi, et al.
Publicado: (2016)

Predicting surgical site infections using a novel nomogram in patients with hepatocelluar carcinoma undergoing hepatectomy
por: Tang, Tian-Yu, et al.
Publicado: (2019)

Hepatic Artery Thrombosis: A Rare Complication of Microwave Ablation in Hepatocelluar Carcinoma
por: Aujla, Amreet K, et al.
Publicado: (2020)

DLEC1 Expression Is Modulated by Epigenetic Modifications in Hepatocelluar Carcinoma Cells: Role of HBx Genotypes
por: Niu, Dandan, et al.
Publicado: (2010)

Combined effect of socioeconomic status, viral hepatitis, and lifestyles on hepatocelluar carcinoma risk in Korea
por: Yun, E H, et al.
Publicado: (2010)

Association between metabolic abnormalities and HBV related hepatocelluar carcinoma in Chinese: A cross-sectional study
por: Zhao, Jinyan, et al.
Publicado: (2011)

Identifying miRNA-mRNA Pairs and Novel miRNAs from Hepatocelluar Carcinoma miRNomes and TCGA Database
por: Wu, Ping, et al.
Publicado: (2019)

Safety and Efficacy of Liver-Directed Radiotherapy in Combination With Lenvatinib for Hepatocelluar Carcinoma With Macroscopic Tumor Thrombosis
por: Yu, Jeong Il, et al.
Publicado: (2022)

Role and limitation of neoadjuvant hepatic arterial infusion chemotherapy in advanced hepatocelluar carcinoma patients with Child-Pugh class A
por: Lee, Beom-Hui, et al.
Publicado: (2019)

Prognostic significance of synergistic hexokinase-2 and beta2-adrenergic receptor expression in human hepatocelluar carcinoma after curative resection
por: Zhang, Zhi-Feng, et al.
Publicado: (2016)

Suppression of E-cadherin Mediates Gallotannin Induced Apoptosis in Hep G2 Hepatocelluar Carcinoma Cells
por: Han, Hee Jeong, et al.
Publicado: (2014)

Melittin Restores PTEN Expression by Down-Regulating HDAC2 in Human Hepatocelluar Carcinoma HepG2 Cells
por: Zhang, Hui, et al.
Publicado: (2014)

Aurora-A promotes chemoresistance in hepatocelluar carcinoma by targeting NF-kappaB/microRNA-21/PTEN signaling pathway
por: Zhang, Kai, et al.
Publicado: (2014)

The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: a propensity score matching analysis
por: Shen, Junyi, et al.
Publicado: (2018)

Precision medicine for hepatocelluar carcinoma using molecular pattern diagnostics: results from a preclinical pilot study
por: Agarwal, Rahul, et al.
Publicado: (2017)

Dosimetric impact of contrast-enhanced 4d computed tomography for stereotactic body radiation therapy of hepatocelluar carcinoma
por: Kamal, Rose, et al.
Publicado: (2021)

Microarray analysis on the lncRNA expression profile in male hepatocelluar carcinoma patients with chronic hepatitis B virus infection
por: Niu, Jianjun, et al.
Publicado: (2016)

Hepatocelluar Carcinoma Risk in Advanced Fibrosis After Sustained Virologic Response: When Can We Safely Stop Hepatocellular Carcinoma Surveillance?
por: Enomoto, Masaru, et al.
Publicado: (2022)

Phosphorylated Smad2 in Advanced Stage Gastric Carcinoma
por: Shinto, Osamu, et al.
Publicado: (2010)

Aspirin enhances cisplatin sensitivity of resistant non-small cell lung carcinoma stem-like cells by targeting mTOR-Akt axis to repress migration
por: Khan, Poulami, et al.
Publicado: (2019)

BIM-Mediated AKT Phosphorylation Is a Key Modulator of Arsenic Trioxide-Induced Apoptosis in Cisplatin-Sensitive and -Resistant Ovarian Cancer Cells
por: Yuan, Zhu, et al.
Publicado: (2011)

Inhibition of hepatocelluar carcinoma MAT2A and MAT2beta gene expressions by single and dual small interfering RNA
por: Wang, Qun, et al.
Publicado: (2008)

Lanthanum Chloride Sensitizes Cisplatin Resistance of Ovarian Cancer Cells via PI3K/Akt Pathway
por: Fang, Shanyu, et al.
Publicado: (2021)

Araf kinase antagonizes Nodal-Smad2 activity in mesendoderm development by directly phosphorylating the Smad2 linker region
por: Liu, Xingfeng, et al.
Publicado: (2013)

Redox-dependent modulation of metformin contributes to enhanced sensitivity of esophageal squamous cell carcinoma to cisplatin
por: Li, Pin Dong, et al.
Publicado: (2017)

Hepcidin inhibits Smad3 phosphorylation in hepatic stellate cells by impeding ferroportin-mediated regulation of Akt
por: Han, Chang Yeob, et al.
Publicado: (2016)

Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiography-assisted CT) with special reference to multi-step hepatocarcinogenesis
por: Matsui, Osamu, et al.
Publicado: (2011)

Berberine Improves Chemo-Sensitivity to Cisplatin by Enhancing Cell Apoptosis and Repressing PI3K/AKT/mTOR Signaling Pathway in Gastric Cancer
por: Kou, Yingying, et al.
Publicado: (2020)

Effect of cyclin-dependent kinase 7 silencing on cisplatin sensitivity in endometrial carcinoma cells
por: LIU, WEN-XIN, et al.
Publicado: (2015)

CD133 promotes gallbladder carcinoma cell migration through activating Akt phosphorylation
por: Li, Chen, et al.
Publicado: (2016)

Repression of metadherin inhibits biological behavior of prostate cancer cells and enhances their sensitivity to cisplatin
por: WEI, YONG-BAO, et al.
Publicado: (2015)

Interaction of microRNA-21/145 and Smad3 domain-specific phosphorylation in hepatocellular carcinoma
por: Wang, Ji Yu, et al.
Publicado: (2017)

Knockdown of Akt Sensitizes Osteosarcoma Cells to Apoptosis Induced by Cisplatin Treatment
por: Zhang, Guoyou, et al.
Publicado: (2011)

Methylation-associated silencing of microRNA-129-3p promotes epithelial-mesenchymal transition, invasion and metastasis of hepatocelluar cancer by targeting Aurora-A
por: Cui, Shiyun, et al.
Publicado: (2016)

USP7 facilitates SMAD3 autoregulation to repress cancer progression in p53-deficient lung cancer
por: Huang, Yu-Ting, et al.
Publicado: (2021)

Phosphorylated AKT1 is associated with poor prognosis in esophageal squamous cell carcinoma
por: Zhu, Zhengfei, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0j2d015ea7mrq66b8fvs99vbd4